SUBSEQUENT EVENTS	9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS NYSE American Filing Delinquency: On April 17, 2020, we received a notice from NYSE Regulation, Inc. stating that we were not in compliance with the NYSE American exchange’s continued listing standards because we failed to timely file restated financial statements for the year ended December 31, 2018, and quarters ended March 31, 2018, June 30, 2018, September 30, 2018, March 31, 2019, June 30, 2019, and September 30, 2019 (“Non-Reliance Periods”) and granting us a six-month initial cure period. We filed restated financial statements for the Non-Reliance Periods on August 25, 2020 and filed our quarterly report on Form 10-Q for the quarter ended March 31, 2020 on September 30, 2020, and June 30, 2020 on November 16, 2020. On October 15, 2020, we were granted an additional three-month period, or until January 15, 2021, in which to file this quarterly report for the quarter ended September 30, 2020, and to regain compliance with the exchange’s timely filing criteria. This Quarterly Report constitutes such filing, and accordingly, as of the date of the filing of this Quarterly Report, we expect to regain compliance with the exchange’s timely filing criteria. On October 6, 2020, our stockholders approved an amendment to the Company’s 2016 Long-Term Incentive Plan to increase the total number of shares of common stock available for issuance thereunder by 800,000 shares, from 600,000 shares to 1,400,000 shares.

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2020

13. SUBSEQUENT EVENTS

NYSE American Filing Delinquency:

On April 17, 2020, we received a notice from NYSE Regulation, Inc. stating that we were not in compliance with the NYSE American exchange’s continued listing standards because we failed to timely file restated financial statements for the year ended December 31, 2018, and quarters ended March 31, 2018, June 30, 2018, September 30, 2018, March 31, 2019, June 30, 2019, and September 30, 2019 (“Non-Reliance Periods”) and granting us a six-month initial cure period. We filed restated financial statements for the Non-Reliance Periods on August 25, 2020 and filed our quarterly report on Form 10-Q for the quarter ended March 31, 2020 on September 30, 2020, and June 30, 2020 on November 16, 2020. On October 15, 2020, we were granted an additional three-month period, or until January 15, 2021, in which to file this quarterly report for the quarter ended September 30, 2020, and to regain compliance with the exchange’s timely filing criteria. This Quarterly Report constitutes such filing, and accordingly, as of the date of the filing of this Quarterly Report, we expect to regain compliance with the exchange’s timely filing criteria.

On October 6, 2020, our stockholders approved an amendment to the Company’s 2016 Long-Term Incentive Plan to increase the total number of shares of common stock available for issuance thereunder by 800,000 shares, from 600,000 shares to 1,400,000 shares.